CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 38.60M | 14.02M | 108.56M | 19.83M | 20.64M |
| Total Depreciation and Amortization | 10.54M | 10.43M | 3.79M | 162.90K | 162.00K |
| Total Amortization of Deferred Charges | -- | 398.00K | -- | -- | -- |
| Total Other Non-Cash Items | 25.96M | 39.37M | -55.85M | 2.71M | 3.55M |
| Change in Net Operating Assets | -32.73M | 30.24M | -25.65M | 7.29M | -4.62M |
| Cash from Operations | 42.38M | 94.46M | 30.86M | 29.99M | 19.74M |
| Capital Expenditure | -729.00K | -1.72M | -505.80K | -23.90K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 1.49M | -310.00M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.69M | 3.53M | 19.19M | -20.19M | -185.00K |
| Cash from Investing | 2.97M | 3.30M | -291.32M | -20.21M | -195.00K |
| Total Debt Issued | -- | 0.00 | 150.00M | -- | -- |
| Total Debt Repaid | -135.00K | -138.80K | -49.20K | -- | -- |
| Issuance of Common Stock | 1.18M | 4.62M | 1.33M | 83.49M | 7.11M |
| Repurchase of Common Stock | -12.62M | -257.40K | -464.10K | -247.50K | -1.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -522.00K | -5.64M | -282.40K | -- | -- |
| Cash from Financing | -12.10M | -1.41M | 150.53M | 83.24M | 6.09M |
| Foreign Exchange rate Adjustments | -- | -1.30K | 300.00 | 800.00 | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.25M | 96.34M | -109.93M | 93.02M | 25.64M |